866-997-4948(US-Canada Toll Free)

Europe Nuclear Medicine-Radiopharmaceuticals Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 114 Pages

Notes:
Sales, means the sales volume of Nuclear Medicine-Radiopharmaceuticals
Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals

This report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Cardinal Health, Inc (US)
GE Healthcare (UK)
Bracco Imaging S.p.A (Italy)
Nordion, Inc. (Canada)
Bayer HealthCare Medical Care (US)
Lantheus Medical Imaging Inc (US)
Advanced Medical Isotope Corporation (US)
Alliance Medical (UK)
Alseres Pharmaceuticals, Inc (US)
Avid Radiopharmaceuticals (US)
Actinium Pharmaceuticals Inc (US)
Ion Beam Applications S.A (Belgium)
Immunomedics, Inc. (US)
Jubilant Pharma (India)
Mallinckrodt Pharmaceuticals (Ireland)
Medi-Radiopharma Ltd (Hungary)
Peregrine Pharmaceuticals, Inc. (US)
Siemens Healthcare (US)
Positron Corporation (US)
Triad Isotopes, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Type III

Split by application, this report focuses on sales, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in each application, can be divided into
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Application 3

Table of Contents

Europe Nuclear Medicine-Radiopharmaceuticals Market Report 2016
1 Nuclear Medicine-Radiopharmaceuticals Overview
1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals
1.2 Classification of Nuclear Medicine-Radiopharmaceuticals
1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.2.3 Type III
1.3 Application of Nuclear Medicine-Radiopharmaceuticals
1.3.1 Diagnostic Applications: SPECT, PET.
1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.3.3 Application 3
1.4 Nuclear Medicine-Radiopharmaceuticals Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Nuclear Medicine-Radiopharmaceuticals (2011-2021)
1.5.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
1.5.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

2 Europe Nuclear Medicine-Radiopharmaceuticals by Manufacturers, Type and Application
2.1 Europe Nuclear Medicine-Radiopharmaceuticals Market Competition by Manufacturers
2.1.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Type
2.2.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)
2.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
2.3 Europe Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Countries
2.3.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Countries (2011-2016)
2.4 Europe Nuclear Medicine-Radiopharmaceuticals (Volume) by Application

3 Germany Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
3.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
3.1.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
3.1.2 Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
3.1.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
3.2 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
3.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
3.4 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

4 France Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
4.1 France Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
4.1.1 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
4.1.2 France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
4.1.4 France Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
4.2 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
4.3 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
4.4 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

5 UK Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
5.1 UK Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
5.1.1 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
5.1.2 UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
5.1.5 UK Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
5.2 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
5.3 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
5.4 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

6 Russia Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
6.1 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
6.1.1 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
6.1.2 Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
6.1.6 Russia Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
6.2 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
6.3 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
6.4 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

7 Italy Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
7.1 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
7.1.1 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
7.1.2 Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
7.1.7 Italy Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
7.2 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
7.3 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
7.4 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

8 Spain Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
8.1 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
8.1.1 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
8.1.2 Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
8.1.8 Spain Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
8.2 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
8.3 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
8.4 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

9 Benelux Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)
9.1 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
9.1.1 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
9.1.2 Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
9.2 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
9.3 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
9.4 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

10 Europe Nuclear Medicine-Radiopharmaceuticals Manufacturers Analysis
10.1 Cardinal Health, Inc (US)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 GE Healthcare (UK)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Bracco Imaging S.p.A (Italy)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Nordion, Inc. (Canada)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Bayer HealthCare Medical Care (US)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Lantheus Medical Imaging Inc (US)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Advanced Medical Isotope Corporation (US)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Alliance Medical (UK)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Alseres Pharmaceuticals, Inc (US)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Avid Radiopharmaceuticals (US)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Actinium Pharmaceuticals Inc (US)
10.12 Ion Beam Applications S.A (Belgium)
10.13 Immunomedics, Inc. (US)
10.14 Jubilant Pharma (India)
10.15 Mallinckrodt Pharmaceuticals (Ireland)
10.16 Medi-Radiopharma Ltd (Hungary)
10.17 Peregrine Pharmaceuticals, Inc. (US)
10.18 Siemens Healthcare (US)
10.19 Positron Corporation (US)
10.20 Triad Isotopes, Inc. (US)

11 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Analysis
11.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast (2016-2021)
14.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.2 France Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.3 UK Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.4 Russia Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.5 Italy Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.6 Spain Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.7 Benelux Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)
14.8 Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)
14.9 Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer


List of Table

List of Tables and Figures

Figure Picture of Nuclear Medicine-Radiopharmaceuticals
Table Classification of Nuclear Medicine-Radiopharmaceuticals
Figure Europe Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture
Table Application of Nuclear Medicine-Radiopharmaceuticals
Figure Europe Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application in 2015
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales of Key Manufacturers (2015 and 2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Figure 2016 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Manufacturers (2015 and 2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table 2016 Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Type (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue Growth Rate by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Countries (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Countries (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Countries (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Countries (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Countries (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Application (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application (2011-2016)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure France Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table France Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table France Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table France Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure UK Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)
Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)
Table Nuclear Medicine-Radiopharmaceuticals Basic Information List
Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Bracco Imaging S.p.A (Italy) Basic Information List
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Nordion, Inc. (Canada) Basic Information List
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Bayer HealthCare Medical Care (US) Basic Information List
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Lantheus Medical Imaging Inc (US) Basic Information List
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Advanced Medical Isotope Corporation (US) Basic Information List
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Alliance Medical (UK) Basic Information List
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Basic Information List
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Avid Radiopharmaceuticals (US) Basic Information List
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Actinium Pharmaceuticals Inc (US) Basic Information List
Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Ion Beam Applications S.A (Belgium) Basic Information List
Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Immunomedics, Inc. (US) Basic Information List
Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Jubilant Pharma (India) Basic Information List
Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Mallinckrodt Pharmaceuticals (Ireland) Basic Information List
Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Medi-Radiopharma Ltd (Hungary) Basic Information List
Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Peregrine Pharmaceuticals, Inc. (US) Basic Information List
Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Siemens Healthcare (US) Basic Information List
Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Positron Corporation (US) Basic Information List
Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Triad Isotopes, Inc. (US) Basic Information List
Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals
Figure Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine-Radiopharmaceuticals
Table Distributors/Traders List
Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *